Pasithea Therapeutics - Warrants (11/08/2026) Current Assets

As of the most recent data (March 2026), KTTAW shows a current assets of $53B. That compares with $6.1B in the prior-year period — up 760.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, KTTAW's current assets is now $53B (was $6.1B) — a 760.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Pasithea Therapeutics - Warrants (11/08/2026) is outperforming or lagging.

Tracking KTTAW's current assets over time shows whether Pasithea Therapeutics - Warrants (11/08/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $53B That compares with $6.1B in the prior-year period — up 760.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Pasithea Therapeutics - Warrants (11/08/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $53B) with ownership activity and broader fundamentals.

Pasithea Therapeutics - Warrants (11/08/2026)'s current assets is $53B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.